Latest market price
45.75
+0.27+0.59%
TA
Loading chart...
Snapshot
| Index | — | P/E | 47.38 | EPS (ttm) | 0.96 | Insider Own | 24.87% | Shs Outstand | 122.08M | Perf Week | 2.27% |
| Market Cap | 5.55B | Forward P/E | 18.80 | EPS next Y | 2.42 | Insider Trans | 0.32% | Shs Float | 106.63M | Perf Month | 20.73% |
| Enterprise Value | 9.21B | PEG | 4.19 | EPS next Q | 0.47 | Short Float | 13.10% | Perf Quarter | 1.97% | ||
| Income | 245.00M | P/S | 1.71 | EPS this Y | 7.96% | Short Ratio | 7.11 | Perf Half Y | 53.34% | ||
| Sales | 3.25B | P/B | 6.16 | EPS next Y | 11.41% | ROA | 2.22% | Short Interest | 13.96M | Perf YTD | -11.91% |
| Book/sh | 7.39 | P/C | 32.85 | EPS next 5Y | 11.31% | ROE | 43.74% | 52W High | 58.94 -22.38% | Perf Year | -10.26% |
| Cash/sh | 1.38 | P/FCF | 11.08 | EPS past 3/5Y | -3.31% -5.99% | ROIC | 9.98% | 52W Low | 29.28 56.25% | Perf 3Y | -0.55% |
| Dividend Est. | 0.52 (1.14%) | EV/EBITDA | 11.24 | Sales past 3/5Y | 20.93% 24.55% | Gross Margin | 93.50% | Volatility | 4.37% 3.32% | Perf 5Y | 24.81% |
| Dividend TTM | 0.51 (1.11%) | EV/Sales | 2.83 | EPS Y/Y TTM | 619.46% | Oper. Margin | 19.53% | ATR (14) | 1.62 | Perf 10Y | — |
| Dividend Ex-Date | Nov 10, 2026 | Quick Ratio | 1.01 | Sales Y/Y TTM | 9.75% | Profit Margin | 7.53% | RSI (14) | 67.03 | Recom | 2.63 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.01 | EPS Q/Q | 8.51% | SMA20 | 10.83% | Beta | 0.54 | Target Price | 48.50 |
| Payout | 26.81% | Debt/Eq | 4.24 | Sales Q/Q | 4.64% | SMA50 | 12.37% | Rel Volume | 1.30 | Prev Close | 45.48 |
| Employees | 6,171 | LT Debt/Eq | 4.20 | Earnings | Feb 11 | SMA200 | 16.78% | Avg Volume | 1.87M | Price | 45.75 |
| IPO Date | Jul 22, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 5.06% -0.38% | Net Debt/EBITDA | 4.47 | Volume | 2,434,540 | Change | 0.59% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-07-26 | Reiterated | Mizuho | Neutral | $43 → $40 |
| Oct-06-26 | Reiterated | Piper Sandler | Neutral | $48 → $40 |
| Sep-16-26 | Reiterated | Mizuho | Neutral | $48 → $43 |
| Aug-19-26 | Reiterated | Morgan Stanley | Overweight | $42 → $50 |
| Aug-03-26 | Reiterated | UBS | Buy | $39 → $55 |
| Aug-03-26 | Reiterated | Cantor Fitzgerald | Neutral | $34 → $41 |
| Jul-31-26 | Reiterated | Goldman Sachs | Neutral | $40 → $45 |
| Jul-31-26 | Reiterated | Barclays | Overweight | $46 → $48 |
| Jul-31-26 | Reiterated | Piper Sandler | Neutral | $44 → $48 |
| Jul-31-26 | Reiterated | Mizuho | Neutral | $39 → $48 |
Latest News· Times ET
Oct-30-26
Oct-29-26
Oct-29-2610:08PM
04:05PM
Ryan Specialty Reports Third Quarter 2026 Resultsbusinesswire.com
Oct-28-26
Oct-27-26
Oct-26-26
Oct-22-26
Oct-22-2611:01AM
Oct-15-26
Oct-15-2606:40AM
Oct-12-26
Oct-12-2607:30AM
Oct-07-26
Oct-07-2610:05AM
Oct-01-26
Oct-01-2604:15PM
Sep-28-26
Sep-23-26
Company
Ryan Specialty Holdings, Inc. functions as a provider of specialized insurance products and comprehensive solutions for the benefit of insurance brokers, agents, and carriers. The company delivers a range of services including distribution, underwriting, product development, administration, and risk management, primarily through its roles as a wholesale broker and a managing underwriter. This firm, established in 2010, maintains its headquarters in Chicago, Illinois.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,253 | 3,051 | 2,516 | 2,078 | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 212 | 288 | 0 | 0 | — | — | — | — | |
| Gross Profit | 3,042 | 2,764 | 2,516 | 2,078 | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 941 | 453 | 1,943 | 1,597 | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | |
| Other Operating Expense | 1,466 | 1,685 | 300 | 243 | — | — | — | — | |
| Operating Income | 635 | 625 | 273 | 238 | — | — | — | — | |
| Interest Expense | 221 | 222 | 158 | 120 | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -95 | -110 | 158 | 120 | — | — | — | — | |
| Net Income Before Taxes | 319 | 293 | 273 | 238 | — | — | — | — | |
| Income Taxes | 50 | 79 | 43 | 43 | — | — | — | — | |
| Consolidated Net Income | 245 | 63 | 95 | 61 | — | — | — | — | |
| Net Income From Continuing Operations | 268 | 214 | 230 | 194 | — | — | — | — | |
| Net Income | 245 | 63 | 95 | 61 | — | — | — | — | |
| EPS (Recurring) | 1.01 | 0.50 | 0.78 | 0.57 | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.01 | 0.50 | 0.78 | 0.57 | — | — | — | — | |
| EPS (Diluted) | 0.96 | 0.47 | 0.71 | 0.52 | — | — | — | — | |
| EBITDA | 819 | 803 | 599 | 473 | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 47.66 | 109.85 | 90.37 | 82.73 | — | — | — | — | |
| Price To Sales Ratio | 1.70 | 2.15 | 3.09 | 2.36 | — | — | — | — | |
| Gross Margin | 93.51 | 90.59 | 100.00 | 100.00 | — | — | — | — | |
| Operating Margin | 19.52 | 20.49 | 10.85 | 11.45 | — | — | — | — | |
| Net Margin | 7.53 | 2.06 | 3.78 | 2.94 | — | — | — | — | |
| Shares Outstanding | 121 | 127 | 121 | 114 | — | — | — | — | |
| Market Capitalization | 5,536 | 6,557 | 7,763 | 4,904 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MULSHINE BRENDAN MARTIN | Co-President and CRO | Sep 08 '26 | Sale | 40.51 | 40,000 | 1,620,320 | 75,366 | Sep 09 |
| Conklin Michael | EVP & CHRO | Aug 13 '26 | Sale | 42.26 | 2,043 | 86,344 | 8,153 | Aug 14 |
| Hamilton Janice M | Chief Financial Officer | Jul 22 '26 | Option Exercise | 0.00 | 5,821 | 0 | 20,395 | Jul 24 |
| Kuczinski Anthony J | Director | Jun 12 '26 | Buy | 35.77 | 500 | 17,885 | 13,072 | Jun 15 |
| Kuczinski Anthony J | Director | Jun 11 '26 | Buy | 34.83 | 2,500 | 87,075 | 12,572 | Jun 15 |
| ROGERS JOHN W JR | Director | Jun 10 '26 | Buy | 35.16 | 7,500 | 263,732 | 117,933 | Jun 11 |
| RYAN PATRICK G | Executive Chairman | Jun 05 '26 | Buy | 32.50 | 120,000 | 3,899,736 | 13,817,859 | Jun 08 |
| Hamilton Janice M | Chief Financial Officer | Jun 03 '26 | Buy | 31.79 | 6,300 | 200,293 | 14,574 | Jun 04 |
| KATZ MARK STEPHEN | EVP & General Counsel | Jun 03 '26 | Buy | 31.07 | 3,215 | 99,888 | 4,332 | Jun 04 |
| Conklin Michael | EVP & CHRO | Apr 01 '26 | Option Exercise | 0.00 | 7,637 | 0 | 12,372 | Apr 02 |
| RYAN PATRICK G JR | Director | Feb 23 '26 | Buy | 39.96 | 25,500 | 1,018,860 | 428,295 | Feb 24 |
| RYAN PATRICK G JR | Director | Feb 20 '26 | Buy | 41.41 | 365 | 15,115 | 256,559 | Feb 24 |
| TURNER TIMOTHY WILLIAM | Chief Executive Officer | Dec 12 '25 | Sale | 53.61 | 129,570 | 6,946,248 | 12,553 | Dec 15 |
| TURNER TIMOTHY WILLIAM | Chief Executive Officer | Dec 11 '25 | Option Exercise | 14.60 | 351,964 | 5,137,080 | 165,942 | Dec 15 |
| ONEX CORP | Director | Dec 05 '25 | Sale | 54.50 | 4,145,621 | 225,936,345 | 0 | Dec 05 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.